Wesbanco Bank Inc Merck & Co., Inc. Transaction History

Wesbanco Bank Inc

$2.89 Billion
Q3 2024

A detailed history of Wesbanco Bank Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Wesbanco Bank Inc holds 353,564 shares of MRK stock, worth $35.3 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares

353,564

Previous 348,737 1.38%

Holding current value

$35.3 Million

Previous $43.2 Million 7.0%

% of portfolio

1.39%

Previous 1.64%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$111.15 - $128.97 $536,521 - $622,538	4,827 Added 1.38%	353,564 $40.2 Million
Q2 2024 Jul 11, 2024	SELL	$123.8 - $132.96 $462,516 - $496,738	-3,736 Reduced 1.06%	348,737 $43.2 Million
Q1 2024 Apr 23, 2024	BUY	$113.24 - $131.95 $12.8 Million - $14.9 Million	113,178 Added 47.3%	352,473 $46.5 Million
Q4 2023 Feb 16, 2024	SELL	$100.18 - $109.02 $10.7 Million - $11.7 Million	-107,279 Reduced 30.95%	239,295 $26.1 Million
Q3 2023 Dec 11, 2023	SELL	$102.95 - $114.33 $188,192 - $208,995	-1,828 Reduced 0.52%	346,574 $35.7 Million
Q2 2023 Jul 13, 2023	SELL	$108.61 - $118.38 $3.46 Million - $3.77 Million	-31,846 Reduced 8.38%	348,402 $40.2 Million
Q1 2023 Apr 21, 2023	SELL	$102.94 - $114.86 $1.17 Million - $1.3 Million	-11,359 Reduced 2.9%	380,248 $40.5 Million
Q4 2022 Jan 18, 2023	BUY	$87.44 - $112.11 $9.71 Million - $12.5 Million	111,069 Added 39.59%	391,607 $43.4 Million
Q3 2022 Oct 13, 2022	SELL	$84.53 - $94.96 $11.6 Million - $13 Million	-136,877 Reduced 32.79%	280,538 $24.2 Million
Q2 2022 Jul 18, 2022	SELL	$83.49 - $94.64 $538,093 - $609,954	-6,445 Reduced 1.52%	417,415 $38.1 Million
Q1 2022 Apr 25, 2022	SELL	$73.51 - $82.4 $51,162 - $57,350	-696 Reduced 0.16%	423,860 $34.8 Million
Q4 2021 Feb 02, 2022	SELL	$72.28 - $90.54 $164,220 - $205,706	-2,272 Reduced 0.53%	424,556 $32.5 Million
Q3 2021 Oct 12, 2021	SELL	$71.68 - $78.83 $145,223 - $159,709	-2,026 Reduced 0.47%	426,828 $32.1 Million
Q2 2021 Aug 09, 2021	BUY	$70.31 - $77.77 $1.41 Million - $1.56 Million	20,108 Added 4.92%	428,854 $33.4 Million
Q1 2021 May 06, 2021	SELL	$68.86 - $81.11 $973,404 - $1.15 Million	-14,136 Reduced 3.34%	408,746 $31.5 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $1.29 Million - $1.46 Million	17,646 Added 4.35%	422,882 $35.1 Million
Q2 2020 Jul 14, 2020	BUY	$70.42 - $80.13 $327,875 - $373,085	4,656 Added 1.16%	405,236 $31.3 Million
Q1 2020 May 12, 2020	BUY	$63.36 - $87.82 $281,128 - $389,657	4,437 Added 1.12%	400,580 $30.8 Million
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $52,831 - $59,614	-681 Reduced 0.17%	396,143 $36 Million
Q3 2019 Nov 07, 2019	SELL	$76.08 - $82.93 $140,215 - $152,839	-1,843 Reduced 0.46%	396,824 $33.4 Million
Q2 2019 Aug 13, 2019	BUY	$69.84 - $81.59 $278,242 - $325,054	3,984 Added 1.01%	398,667 $33.4 Million
Q1 2019 May 09, 2019	SELL	$69.58 - $79.36 $355,345 - $405,291	-5,107 Reduced 1.28%	394,683 $32.8 Million
Q4 2018 Feb 05, 2019	SELL	$65.24 - $75.71 $492,431 - $571,459	-7,548 Reduced 1.85%	399,790 $30.5 Million
Q3 2018 Nov 09, 2018	SELL	$57.69 - $67.84 $439,136 - $516,398	-7,612 Reduced 1.83%	407,338 $28.9 Million
Q2 2018 Aug 08, 2018	BUY	$50.83 - $59.72 $109,589 - $128,756	2,156 Added 0.52%	414,950 $25.2 Million
Q1 2018 May 18, 2018	BUY	$50.96 - $59.23 $3.86 Million - $4.49 Million	75,831 Added 22.5%	412,794 $22.5 Million
Q4 2017 Feb 01, 2018	SELL	$51.62 - $61.64 $3.49 Million - $4.16 Million	-67,556 Reduced 16.7%	336,963 $19 Million
Q3 2017 Nov 02, 2017	BUY	$58.67 - $63.13 $785,121 - $844,805	13,382 Added 3.42%	404,519 $25.9 Million
Q2 2017 Aug 08, 2017	BUY	N/A	391,137	391,137 $25.1 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.

Account

Wesbanco Bank Inc Merck & Co., Inc. Transaction History